Table 2.
Pearson correlations between serum superoxide dismutase and parameters of vascular structure and function and cardiovascular risk.
| Superoxide dismutase | |||||
|---|---|---|---|---|---|
| All patients | DIA + HYP | DIA | HYP | Control | |
| Intima-media thickness medium average | −0.08 | 0.06 | 0.45 | −0.12 | −0.22 |
| Intima-media thickness maximum average | −0.06 | 0.06 | 0.41 | −0.07 | −0.22 |
| Pulse wave velocity | −0.15∗ | −0.06 | −0.03 | −0.16∗ | 0.25 |
| Peripheral augmentation index | −0.16∗∗ | −0.08 | −0.09 | −0.13 | −0.37∗ |
| Central augmentation index | −0.16∗∗ | −0.01 | −0.18 | −0.10 | −0.35∗ |
| AASI | −0.19∗∗ | −0.32∗ | 0.20 | −0.24∗∗ | −0.15 |
| Pulse pressure | −0.17∗∗ | −0.20 | −0.07 | −0.18∗ | −0.19 |
| D'Agostino cardiovascular risk | −0.03 | −0.09 | 0.46 | −0.06 | −0.10 |
| 8-Hydroxy-2-deoxyguanosine | −0.17 | −0.29 | 0.21 | −0.21 | −0.22 |
| Uric acid | 0.19∗∗ | 0.19 | 0.25 | 0.20∗∗ | 0.28 |
| HDL | −0.18∗∗ | −0.10 | −0.22 | −0.18∗ | −0.28 |
| LDL | 0.02 | −0.06 | 0.40 | 0.13 | −0.10 |
| Triglycerides | 0.19∗∗ | 0.19 | 0.44 | 0.20∗∗ | 0.25 |
AASI: ambulatory arterial stiffness index; DIA: diabetic nonhypertensive patients; DIA + HYP: diabetic hypertensive patients; HDL: cholesterol associated with high density lipoproteins; HYP: hypertensive patients; LDL: cholesterol associated with low density lipoproteins. Statistical significant differences: ∗ p < 0.05; ∗∗ p < 0.01.